The store will not work correctly when cookies are disabled.
3-(3,5-Dimethyl-2-oxopyridin-1(2H)-yl)-2-methylacrylonitrile
ID: ALA4518627
PubChem CID: 155541424
Max Phase: Preclinical
Molecular Formula: C11H12N2O
Molecular Weight: 188.23
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: C/C(C#N)=C/n1cc(C)cc(C)c1=O
Standard InChI: InChI=1S/C11H12N2O/c1-8-4-10(3)11(14)13(6-8)7-9(2)5-12/h4,6-7H,1-3H3/b9-7-
Standard InChI Key: NVXGALADZOKAJO-CLFYSBASSA-N
Molfile:
RDKit 2D
14 14 0 0 0 0 0 0 0 0999 V2000
14.7750 -7.3536 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3664 -8.0627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7750 -8.7718 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5922 -8.7718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0008 -9.4768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5922 -10.1858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1836 -10.8949 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8180 -9.4768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3664 -9.4768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5451 -9.4768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1365 -10.1858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1365 -8.7718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5451 -8.0627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1365 -7.3536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 3 0
5 8 1 0
3 9 1 0
9 10 2 0
10 11 1 0
10 12 1 0
12 13 2 0
2 13 1 0
13 14 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 188.23 | Molecular Weight (Monoisotopic): 188.0950 | AlogP: 1.85 | #Rotatable Bonds: 1 |
Polar Surface Area: 45.79 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 1.43 | CX LogD: 1.43 |
Aromatic Rings: 1 | Heavy Atoms: 14 | QED Weighted: 0.63 | Np Likeness Score: -0.47 |
References
1. Stadler M, Monticelli S, Seidel T, Luger D, Salzer I, Boehm S, Holzer W, Schwarzer C, Urban E, Khom S, Langer T, Pace V, Hering S.. (2018) Design, Synthesis, and Pharmacological Evaluation of Novel β2/3 Subunit-Selective γ-Aminobutyric Acid Type A (GABAA) Receptor Modulators., 62 (1): [PMID:30289721] [10.1021/acs.jmedchem.8b00859] |